1 / 8

Clostridium difficile Infection (CDI) Therapeutics - Pipelin

Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Clostridium difficile (CDI) Therapeutics market. The report identifies the key trends shaping and driving the global Clostridium difficile (CDI) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders.

aarkresearch
Download Presentation

Clostridium difficile Infection (CDI) Therapeutics - Pipelin

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aarkstore Enterprise specialize in providing online market business information on market research reports, books, magazines, conference booking at competitive prices, and strive to provide excellent and innovative service to our customers.

  2. Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 • Date: 29 February 2012 • Pages: 64 • SummaryCompany, the industry analysis specialist, has released its new report, “Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Clostridium difficile (CDI) Therapeutics market. The report identifies the key trends shaping and driving the global Clostridium difficile (CDI) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Clostridium difficile (CDI) Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Company team of industry experts.Scope- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Clostridium difficile (CDI) Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.- Analysis of the current and future competition in the seven key countries Clostridium difficile (CDI) Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Clostridium difficile (CDID) Therapeutics market.- Analysis of key recent licensing and partnership agreements in Clostridium difficile (CDI) Therapeutics market

  3. Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Reasons to buyThe report will enhance your decision making capability. It will allow you to - - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Clostridium difficile (CDI) Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Clostridium difficile (CDI) Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What the next big thing in the global Clostridium difficile (CDI) Therapeutics market landscape? – Identify, understand and capitalize.

  4. 1.1 List of Tables 51.2 List of Figures 62 CDI Therapeutics - Introduction 72.1 Overview 72.2 Pathophysiology 72.3 Epidemiology 72.4 Etiology 82.5 Symptoms 82.6 Diagnosis 92.7 Treatment and Management Pattern 92.8 GlobalData Report Guidance 103 CDI Therapeutics - Market Characterization 113.1 CDI Therapeutics Global Market Size  (2006-2011) 113.2 CDI Therapeutics Global Market Forecast  (2011-2019) 123.3 CDI Therapeutics Market (2006-2011) - The US 133.4 CDI Therapeutics Market Forecast (2011-2019) - The US 143.5 CDI Therapeutics Market (2006-2011) - France 153.6 CDI Therapeutics Market Forecast (2011-2019) - France 163.7 CDI Therapeutics Market (2006-2011) - Germany 173.8 CDI Therapeutics Market Forecast (2011-2019) - Germany 183.9 CDI Therapeutics Market (2006-2011) - Spain 193.10 CDI Therapeutics Market Forecast (2011-2019) - Spain 203.11 CDI Therapeutics Market (2006-2011) - Italy 213.12 CDI Therapeutics Market Forecast (2011-2019) - Italy 223.13 CDI Therapeutics Market (2006-2011) - The UK 233.14 CDI Therapeutics Market Forecast (2011-2019) - The UK 243.15 CDI Therapeutics Market (2006-2011) - Japan 253.16 CDI Therapeutics Market Forecast (2011-2019) - Japan 263.17 Drivers and Barriers for the CDI Therapeutics Market 273.17.1 CDI Therapeutics Market Drivers 273.17.2 CDI Therapeutics Market Barriers 283.18 Opportunity and Unmet Need 283.19 Key Takeaway 29

  5. 4 CDI Therapeutics - Competitive Assessment 304.1 Overview 304.2 Strategic Competitor Assessment 304.3 Product Profiles of the Major Market Products in the CDI Therapeutics Market 314.3.1 Vancocin (Vancomycin Hydrochloride Capsules) 314.3.2 Metronidazole 334.3.3 Dificid (fidaxomicin) 334.4 CDI Therapeutics - Major Marketed Products Comparison 344.5 Key Takeaway 345 CDI Therapeutics - Pipeline Assessment 355.1 Overview 355.2 Strategic Pipeline Assessment 355.3 CDI Therapeutics Market - Pipeline Assessment by Phase of Development 355.3.1 CDI Therapeutics market - Phase III Pipeline 355.3.2 CDI Therapeutics Market - Phase II Pipeline 365.3.3 CDI Therapeutics Market - Phase I Clinical Pipeline 365.3.4 CDI Therapeutics Market - Preclinical Pipeline 365.4 CDI Therapeutics - Pipeline by Mechanism of Action 375.5 Technology Trends Analytical Framework 385.6 CDI Therapeutics Market - Most Promising Drugs under Clinical Development 395.7 Most Promising Drug Profiles 395.7.1 MK-3415A 395.8 Key Takeaway 406 CDI Therapeutics - Clinical Trials Mapping 416.1 Clinical Trials by Region/Country (US, EU-5 and Japan) 416.2 Clinical Trials by Phase of Clinical Development 426.3 Clinical Trials by Trial Status 436.4 Prominent Sponsors 446.4.1 Brief Profiles of Top 10 Companies Participating in Therapeutics Clinical Trials 45

  6. 7 CDI Therapeutics - Strategic Assessment 467.1 Key Events Impacting the Future Market 467.2 Future Market Competition Scenario 478 CDI Therapeutics - Future Players 488.1 Introduction 488.2 Company Profiles 488.2.1 Merck & Co., Inc 488.2.2 Sanofi 508.2.3 Cubist Pharmaceuticals, Inc. 528.2.4 Novartis AG. 538.2.5 ViroPharma Incorporated 558.2.6 Actelion Ltd. 568.2.7 Key Takeaway 579 CDI Therapeutics - Licensing & Partnership Deals 5810 CDI therapeutics - Appendix 5910.1 Market Definitions 5910.2 Acronyms 5910.3 Methodology 6010.3.1 Coverage 6010.3.2 Secondary Research 6010.3.3 Forecasting 6110.3.4 Primary Research 6310.3.5 Expert Panel Validation 6310.4 Contact Us 6310.5 Disclaimer 6310.6 Bibliography 64 

  7. For more information, please visit: • http://www.aarkstore.com/reports/Clostridium-difficile-Infection-CDI-Therapeutics-Pipeline-Assessment-and-Market-Forecasts-to-2019-198821.htmlOr email us at contact@aarkstore.com or call +919272852585 • Related Reports • Vemurafenib - Comprehensive patent searchColesevelam - Comprehensive patent searchRifaximin - Comprehensive patent searchNevirapine - Comprehensive patent searchLiraglutide - Comprehensive patent searchVilazodone - Comprehensive patent searchHexylaminolevulinic Acid - Comprehensive patent searchTreprostinil - Comprehensive patent searchPatient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage ComplianceExpress Scripts, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report

  8. Contact Us Aarkstore Enterprise Tel : +912227453309 Mobile No:+08149852585 Email : contact@aarkstore.com Website : http://www.aarkstore.com Blog: http://www.emarketreports.com http://teju-aarkstoreenterprise.blogspot.in Follow us on twitter: http://twitter.com/aarkstoredotcom http://in.linkedin.com/in/aarkstore http://www.facebook.com/aarkstoreenterprise

More Related